The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Adrenergic Nervous System in Heart Failure: Pathophysiology and Therapy
Open accessAbstract
Heart failure (HF), the leading cause of death in the western world, develops when a cardiac injury or insult impairs the ability of the heart to pump blood and maintain tissue perfusion. It is characterized by a complex interplay of several neurohormonal mechanisms that become activated in the syndrome to try and sustain cardiac output in the face of decompensating function. Perhaps the most prominent among these neurohormonal mechanisms is the adrenergic (or sympathetic) nervous system (ANS), whose activity and outflow are enormously elevated in HF. Acutely, and if the heart works properly, this activation of the ANS will promptly restore cardiac function. However, if the cardiac insult persists over time, chances are the ANS will not be able to maintain cardiac function, the heart will progress into a state of chronic decompensated HF, and the hyperactive ANS will continue to push the heart to work at a level much higher than the cardiac muscle can handle. From that point on, ANS hyperactivity becomes a major problem in HF, conferring significant toxicity to the failing heart and markedly increasing its morbidity and mortality. The present review discusses the role of the ANS in cardiac physiology and in HF pathophysiology, the mechanisms of regulation of ANS activity and how they go awry in chronic HF, methods of measuring ANS activity in HF, the molecular alterations in heart physiology that occur in HF, along with their pharmacological and therapeutic implications, and, finally, drugs and other therapeutic modalities used in HF treatment that target or affect the ANS and its effects on the failing heart.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
O'Connor (2009) · doi:10.1001/jama.2009.454 · Cited by 2,173
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.15.1967 · Cited by 1,499
Bristow, M. R., Ginsburg, R., Umans, V, Fowler, M., Minobe, W., Rasmussen, R., Zera, P., Menlove, R., Shah, P., & Jamieson, S. (1986) · Circulation Research · doi:10.1161/01.res.59.3.297 · Cited by 1,327
Calcium Cycling and Signaling in Cardiac Myocytes
Bers, D. M. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100455 · Cited by 1,302
Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A
Daaka, Y., Luttrell, L. M., & Lefkowitz, R. J. (1997) · Nature · doi:10.1038/36362 · Cited by 1,270
International Union of Pharmacology nomenclature of adrenoceptors.
Bylund, D. B., Eikenberg, D. C., Hieble, J. P., Langer, S. Z., Lefkowitz, R. J., Minneman, K. P., Molinoff, P. B., Ruffolo, R. R., & Trendelenburg, U. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06780-8 · Cited by 1,218
The Sympathetic Nervous System in Heart Failure
Triposkiadis, F., Karayannis, G., Giamouzis, G., Skoularigis, J., Louridas, G., & Butler, J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.015 · Cited by 978
A family of hyperpolarization-activated mammalian cation channels
Ludwig, A., Zong, X., Jeglitsch, M., Hofmann, F., & Biel, M. (1998) · Nature · doi:10.1038/31255 · Cited by 943
Seven-transmembrane-spanning receptors and heart function
Rockman, H. A., Koch, W. J., & Lefkowitz, R. J. (2002) · Nature · doi:10.1038/415206a · Cited by 938
Self-citationLeft Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure
Birks, E. J., Tansley, P. D., Hardy, J., George, R. S., Bowles, C. T., Burke, M., Banner, N. R., Khaghani, A., & Yacoub, M. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053063 · Cited by 885
Ungerer, M., Böhm, M., Elce, J. S., Erdmann, E., & Lohse, M. J. (1993) · Circulation · doi:10.1161/01.cir.87.2.454 · Cited by 878
Mechanisms and Models in Heart Failure: The Biomechanical Model and Beyond
Mann, D. L., & Bristow, M. R. (2005) · Circulation · doi:10.1161/circulationaha.104.500546 · Cited by 867
Adrenergic effects on the biology of the adult mammalian cardiocyte.
Mann, D. L., Kent, R. L., Parsons, B., & Cooper, G. (1992) · Circulation · doi:10.1161/01.cir.85.2.790 · Cited by 866
Lyon, A. R., Rees, P. S., Prasad, S., Poole-Wilson, P. A., & Harding, S. E. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1066 · Cited by 865
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions
Esler, M., Jennings, G., Lambert, G., Meredith, I., Horne, M., & Eisenhofer, G. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.963 · Cited by 794 · cited 1×
“nephrine reuptake as well as norepinephrine clearance from the circulation.(63) The two standard techniques to assess hu-”
BackgroundAldosterone in Congestive Heart Failure
Weber, K. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000050 · Cited by 770
What Is the Role of β-Adrenergic Signaling in Heart Failure?
Lohse, M. J., Engelhardt, S., & Eschenhagen, T. (2003) · Circulation Research · doi:10.1161/01.res.0000102042.83024.ca · Cited by 764
Mancini, D. M., Walter, G., Reichek, N., Lenkinski, R., McCully, K. K., Mullen, J. L., & Wilson, J. R. (1992) · Circulation · doi:10.1161/01.cir.85.4.1364 · Cited by 735
Cardiac Function in Mice Overexpressing the β-Adrenergic Receptor Kinase or a βARK Inhibitor
Koch, W. J., Rockman, H. A., Samama, P., Hamilton, R., Bond, R. A., Milano, C. A., & Lefkowitz, R. J. (1995) · Science · doi:10.1126/science.7761854 · Cited by 719
Self-citationPitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708
Communal, C., Singh, K., Pimentel, D. R., & Colucci, W. S. (1998) · Circulation · doi:10.1161/01.cir.98.13.1329 · Cited by 690
Angelini, P. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1235 · Cited by 683
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
Reiter, E., & Lefkowitz, R. J. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.008 · Cited by 666
Communal, C., Singh, K., Sawyer, D. B., & Colucci, W. S. (1999) · Circulation · doi:10.1161/01.cir.100.22.2210 · Cited by 562
(2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.002 · Cited by 557
β 2 -Adrenergic Receptor Redistribution in Heart Failure Changes cAMP Compartmentation
Nikolaev, V. O., Moshkov, A., Lyon, A. R., Miragoli, M., Novak, P., Paur, H., Lohse, M. J., Korchev, Y. E., Harding, S. E., & Gorelik, J. (2010) · Science · doi:10.1126/science.1185988 · Cited by 556
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.
Dzau, V. J., Colucci, W. S., Hollenberg, N. K., & Williams, G. H. (1981) · Circulation · doi:10.1161/01.cir.63.3.645 · Cited by 534
Small, K. M., Wagoner, L. E., Levin, A. M., Kardia, S. L. R., & Liggett, S. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020803 · Cited by 530
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
Hein, L., Altman, J. D., & Kobilka, B. K. (1999) · Nature · doi:10.1038/46040 · Cited by 520
Rockman, H. A., Chien, K. R., Choi, D.-J., Iaccarino, G., Hunter, J. J., Ross, J., Lefkowitz, R. J., & Koch, W. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7000 · Cited by 489
Self-citationZhu, W.-Z., Zheng, M., Koch, W. J., Lefkowitz, R. J., Kobilka, B. K., & Xiao, R.-P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1607 · Cited by 464
Self-citationOlshansky, B., Sabbah, H. N., Hauptman, P. J., & Colucci, W. S. (2008) · Circulation · doi:10.1161/circulationaha.107.760405 · Cited by 456
Liggett, S. B., Mialet-Perez, J., Thaneemit-Chen, S., Weber, S. A., Greene, S. M., Hodne, D., Nelson, B., Morrison, J., Domanski, M. J., Wagoner, L. E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509937103 · Cited by 454
Clonidine binds to imidazole binding sites as well as α2-adrenoceptors in the ventrolateral medulla
Ernsberger, P., Meeley, M. P., Mann, J. J., & Reis, D. J. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90125-7 · Cited by 445
Chesley, A., Lundberg, M. S., Asai, T., Xiao, R.-P., Ohtani, S., Lakatta, E. G., & Crow, M. T. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1172 · Cited by 422
Tackling heart failure in the twenty-first century
Mudd, J. O., & Kass, D. A. (2008) · Nature · doi:10.1038/nature06798 · Cited by 406
Sistonen, J., Sajantila, A., Lao, O., Corander, J., Barbujani, G., & Fuselli, S. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000239974.69464.f2 · Cited by 398
Gauthier, C., Leblais, V, Kobzik, L., Trochu, J. N., Khandoudi, N., Bril, A., Balligand, J. L., & Le Marec, H. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2191 · Cited by 397
New Positive Inotropic Agents in the Treatment of Congestive Heart Failure
Colucci, W. S., Wright, R. F., & Braunwald, E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601303140506 · Cited by 397
Liggett, S. B., Tepe, N. M., Lorenz, J. N., Canning, A. M., Jantz, T. D., Mitarai, S., Yatani, A., & Dorn, G. W. (2000) · Circulation · doi:10.1161/01.cir.101.14.1707 · Cited by 395
Myocardial imaging with a radioiodinated norepinephrine storage analog.
Wieland, D. M., Brown, L. E., Rogers, W. L., Worthington, K. C., Wu, J. L., Clinthorne, N. H., Otto, C. A., Swanson, D. P., & Beierwaltes, W. H. (1981) · PubMed · Cited by 387
Cohn, J. N., Pfeffer, M. A., Rouleau, J., Sharpe, N., Swedberg, K., Straub, M., Wiltse, C., Wright, T. J., & for the MOXCON Investigators (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00163-6 · Cited by 384
Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli
Mori, H., Ishikawa, S., Kojima, S., Hayashi, J., Watanabe, Y., Hoffman, J. I. E., & Okino, H. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.2.192 · Cited by 377
The new biology of aldosterone
Connell, J. M. C., & Davies, E. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06017 · Cited by 356
Perez, J. M., Rathz, D. A., Petrashevskaya, N. N., Hahn, H. S., Wagoner, L. E., Schwartz, A., Dorn, G. W., & Liggett, S. B. (2003) · Nature Medicine · doi:10.1038/nm930 · Cited by 333
Aldosterone and end-organ damage
Brown, N. J. (2005) · Current Opinion in Nephrology and Hypertension · doi:10.1097/01.mnh.0000165889.60254.98 · Cited by 320
A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure
Liggett, S. B., Cresci, S., Kelly, R. J., Syed, F. M., Matkovich, S. J., Hahn, H. S., Diwan, A., Martini, J. S., Sparks, L., Parekh, R. R., et al. (2008) · Nature Medicine · doi:10.1038/nm1750 · Cited by 319
Self-citationPhysiological significance of α2-adrenergic receptor subtype diversity: one receptor is not enough
Philipp, M., Brede, M., & Hein, L. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00123.2002 · Cited by 318
Knowlton, K. U., Michel, M. C., Itani, M., Shubeita, H. E., Ishihara, K., Brown, J. H., & Chien, K. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82267-0 · Cited by 301
Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.
Sisson, J. C., Shapiro, B., MEYERS, L., Mallette, S., Mangner, T. J., Wieland, D. M., Glowniak, J. V., Sherman, P., & Beierwaltes, W. H. (1987) · PubMed · Cited by 286
Altered Beta-adrenergic Receptor Gene Regulation and Signaling in Chronic Heart Failure
Port, J. D., & Bristow, M. R. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1358 · Cited by 280
Beta-adrenoceptors in cardiac disease
Brodde, O.-E. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90030-h · Cited by 264
Iaccarino, G., Tomhave, E. D., Lefkowitz, R. J., & Koch, W. J. (1998) · Circulation · doi:10.1161/01.cir.98.17.1783 · Cited by 256
Self-citationAdrenal GRK2 upregulation mediates sympathetic overdrive in heart failure
Lymperopoulos, A., Rengo, G., Funakoshi, H., Eckhart, A. D., & Koch, W. J. (2007) · Nature Medicine · doi:10.1038/nm1553 · Cited by 237
Self-citationLevin, M. C., Marullo, S., Muntaner, O., Andersson, B., & Magnusson, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200681200 · Cited by 231
Dorn, G. W., Tepe, N. M., Lorenz, J. N., Koch, W. J., & Liggett, S. B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6400 · Cited by 230
Self-citationCardiac neuronal hierarchy in health and disease
Armour, J. A. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00183.2004 · Cited by 229
Regulation of G Protein-Coupled Receptor Kinases
Penn, R. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00053-0 · Cited by 212
Aldosterone and end-organ damage
Marney, A. M., & Brown, N. J. (2007) · Clinical Science · doi:10.1042/cs20070123 · Cited by 212
BORJESSON, M. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1994 · Cited by 206
Rengo, G., Lymperopoulos, A., Zincarelli, C., Donniacuo, M., Soltys, S., Rabinowitz, J. E., & Koch, W. J. (2009) · Circulation · doi:10.1161/circulationaha.108.803999 · Cited by 205
Self-citationThe MERIT-HF Study Group, White, H. L., de Boer, R. A., Maqbool, A., Greenwood, D., van Veldhuisen, D. J., Cuthbert, R., Ball, S. G., Hall, A. S., & Balmforth, A. J. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00044-8 · Cited by 199
Arriza, J., Dawson, T., Simerly, R., Martin, L., Caron, M., Snyder, S., & Lefkowitz, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-10-04045.1992 · Cited by 195
Despa, S., Bossuyt, J., Han, F., Ginsburg, K. S., Jia, L.-G., Kutchai, H., Tucker, A. L., & Bers, D. M. (2005) · Circulation Research · doi:10.1161/01.res.0000176532.97731.e5 · Cited by 180
Brede, M., Wiesmann, F., Jahns, R., Hadamek, K., Arnolt, C., Neubauer, S., Lohse, M. J., & Hein, L. (2002) · Circulation · doi:10.1161/01.cir.0000036600.39600.66 · Cited by 180
Terra, S. G., Hamilton, K. K., Pauly, D. F., Lee, C. R., Herbert Patterson, J., Adams, K. F., Schofield, R. S., Belgado, B. S., Hill, J. A., Aranda, J. M., et al. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200504000-00006 · Cited by 174
Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes
Philipp, M., & Hein, L. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.10.004 · Cited by 172
Vagus nerve stimulation: From pre-clinical to clinical application: Challenges and future directions
De Ferrari, G. M., & Schwartz, P. J. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9216-0 · Cited by 169
Vagus nerve stimulation in experimental heart failure
Sabbah, H. N., Ilsar, I., Zaretsky, A., Rastogi, S., Wang, M., & Gupta, R. C. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9209-z · Cited by 166
Rockman, H. A., Choi, D.-J., Akhter, S. A., Jaber, M., Giros, B., Lefkowitz, R. J., Caron, M. G., & Koch, W. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18180 · Cited by 165
Self-citationRaake, P. W. J., Schlegel, P., Ksienzyk, J., Reinkober, J., Barthelmes, J., Schinkel, S., Pleger, S., Mier, W., Haberkorn, U., Koch, W. J., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehr447 · Cited by 165
Self-citationMatkovich, S. J., Diwan, A., Klanke, J. L., Hammer, D. J., Marreez, Y., Odley, A. M., Brunskill, E. W., Koch, W. J., Schwartz, R. J., & Dorn, G. W. (2006) · Circulation Research · doi:10.1161/01.res.0000247932.71270.2c · Cited by 165
Self-citationSystemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure
Grose, R., Strain, J., Greenberg, M., & LeJemtel, T. H. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80231-5 · Cited by 160
Differential Control of Adrenal and Sympathetic Catecholamine Release by α2-Adrenoceptor Subtypes
Brede, M., Nagy, G., Philipp, M., Sørensen, J. B., Lohse, M. J., & Hein, L. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0035 · Cited by 159
Fraga, R. F., Franco, F. G. M., Roveda, F., de Matos, L. D. N. J., Braga, A., Rondon, M. U. P. B., Rotta, D. R., Brum, P. C., Barretto, A. C. P., Middlekauff, H. R., et al. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.03.003 · Cited by 139
Lindley, T. E., Doobay, M. F., Sharma, R. V., & Davisson, R. L. (2003) · Circulation Research · doi:10.1161/01.res.0000112964.40701.93 · Cited by 139
Huang, Y., Wright, C. D., Merkwan, C. L., Baye, N. L., Liang, Q., Simpson, P. C., & O’Connell, T. D. (2007) · Circulation · doi:10.1161/circulationaha.106.664862 · Cited by 138
Heart-brain interactions in cardiac arrhythmias: role of the autonomic nervous system.
Zipes, D. P. (2008) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.75.suppl_2.s94 · Cited by 136
Inotropes in the management of acute heart failure
Petersen, J. W., & Felker, G. M. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000296273.72952.39 · Cited by 133
Leosco, D., Rengo, G., Iaccarino, G., Golino, L., Marchese, M., Fortunato, F., Zincarelli, C., Sanzari, E., Ciccarelli, M., Galasso, G., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm109 · Cited by 131
Self-citationAdrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation
Lymperopoulos, A., Rengo, G., & Koch, W. J. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.10.005 · Cited by 127
Self-citationSehnert, A. J., Daniels, S. E., Elashoff, M. R., Wingrove, J. A., Burrow, C. R., Horne, B. D., Muhlestein, J. B., Donahue, M., Liggett, S. B., Anderson, J. L., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.022 · Cited by 127
de Groote, P., Helbecque, N., Lamblin, N., Hermant, X., Fadden, E. P. M., Hossein-Foucher, C., Amouyel, P., Dallongeville, J., & Bauters, C. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200503000-00001 · Cited by 124
Sympathetic Activation in Heart Failure and Its Treatment With β-Blockade
Pepper, G. S., & Lee, R. W. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.3.225 · Cited by 123
Adaptations in autonomic function during exercise training in heart failure
Negrão, C. E., & Middlekauff, H. R. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9057-7 · Cited by 122
Fu, Y. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.01.039 · Cited by 121
Sympathetic neuronal regulation of the heart in aging and heart failure
Kaye, D. M., & Esler, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.02.012 · Cited by 121
GRK2 as a novel gene therapy target in heart failure
Rengo, G., Lymperopoulos, A., Leosco, D., & Koch, W. J. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.08.014 · Cited by 119
Self-citationBacks, J., Haunstetter, A., Gerber, S. H., Metz, J., Borst, M. M., Strasser, R. H., Kübler, W., & Haass, M. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1319 · Cited by 116
Clinical and Genetic Modifiers of Long-Term Survival in Heart Failure
Cresci, S., Kelly, R. J., Cappola, T. P., Diwan, A., Dries, D. L., Kardia, S. L. R., & Dorn, G. W. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.009 · Cited by 113
Lymperopoulos, A., Rengo, G., Zincarelli, C., Kim, J., Soltys, S., & Koch, W. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811706106 · Cited by 113
Self-citationAbnormal cardiac function associated with sympathetic nervous system hyperactivity in mice
Brum, P. C., Kosek, J. C., Patterson, A., Bernstein, D., & Kobilka, B. K. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01063.2001 · Cited by 113
Jacobson, A. F., Lombard, J., Banerjee, G., & Camici, P. G. (2009) · Journal of Nuclear Cardiology · doi:10.1007/s12350-008-9008-2 · Cited by 112
Ernsberger, P. R., Meeley, M. P., & Reis, D. J. (1988) · Brain Research · doi:10.1016/0006-8993(88)91409-6 · Cited by 112
The development of positive inotropic agents for chronic heart failure: How have we gone astray?
Packer, M. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90474-f · Cited by 112
Lymperopoulos, A., Rengo, G., Gao, E., Ebert, S. N., Dorn, G. W., & Koch, W. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077859 · Cited by 111
Self-citationMagnusson, Y., Levin, M. C., Eggertsen, R., Nyström, E., Mobini, R., Schaufelberger, M., & ANDERSSON, B. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.06.004 · Cited by 111
Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction
Benedict, C. R., Francis, G. S., Shelton, B. J., Johnstone, D. E., Kubo, S. H., Kirlin, P. C., Nicklas, J. M., Liang, C., Konstam, M. A., Greenberg, B., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80748-6 · Cited by 110
Region-Specific Neuropeptide Y Overflows at Rest and During Sympathetic Activation in Humans
Morris, M. J., Cox, H. S., Lambert, G. W., Kaye, D. M., Jennings, G., Meredith, I. T., & Esler, M. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.137 · Cited by 109
Skeberdis, V. A., Gendvilienė, V., Zablockaitė, D., Treinys, R., Mačianskienė, R., Bogdelis, A., Jurevičius, J., & Fischmeister, R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32519 · Cited by 109
Wang, H., Huang, B. S., Ganten, D., & Leenen, F. H. H. (2004) · Circulation Research · doi:10.1161/01.res.0000120864.21172.5a · Cited by 99
Akhter, S. A., Eckhart, A. D., Rockman, H. A., Shotwell, K. F., Lefkowitz, R. J., & Koch, W. J. (1999) · Circulation · doi:10.1161/01.cir.100.6.648 · Cited by 98
Self-citationSulakhe, P. V., & Vo, X. T. (1995) · Molecular and Cellular Biochemistry · doi:10.1007/bf01076569 · Cited by 97
Adrenergic Signaling Polymorphisms and Their Impact on Cardiovascular Disease
Dorn, G. W. (2010) · Physiological Reviews · doi:10.1152/physrev.00001.2010 · Cited by 96
Azevedo, E. R., & Parker, J. D. (1999) · Circulation · doi:10.1161/01.cir.100.3.274 · Cited by 95
Angiotensin II stimulates norepinephrine uptake in hypothalamus-brain stem neuronal cultures
Sumners, C., & Raizada, M. K. (1986) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1986.250.2.c236 · Cited by 95
Neumeister, A., Charney, D. S., Belfer, I., Geraci, M. F., Holmes, C. S., Sharabi, Y., Alim, T. N., Bonne, O. B., Luckenbaugh, D. A., Manji, H. K., et al. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200503000-00002 · Cited by 92
Todd, G. L., Baroldi, G., Pieper, G. M., Clayton, F. C., & Eliot, R. S. (1985) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(85)80064-x · Cited by 89
Chen, L., Meyers, D. E., Javorsky, G., Burstow, D. J., Lolekha, P., Lucas, M., Semmler, A., Francis, S. M. S., Fong, K. M., Yang, I. A., et al. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282ef7354 · Cited by 89
Antiadrenergic Therapy of Chronic Heart Failure
Bristow, M. R. (2003) · Circulation · doi:10.1161/01.cir.0000054530.87613.36 · Cited by 89
Lymperopoulos, A., Rengo, G., Zincarelli, C., Kim, J., & Koch, W. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.08.635 · Cited by 83
Self-citationSandilands, A., O’Shaughnessy, K. M., & Brown, M. J. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705030 · Cited by 82
Cardiac 1-adrenergic drive in pathological remodelling
Woodcock, E. A., Du, X.-J., Reichelt, M. E., & Graham, R. M. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm078 · Cited by 82
Aggarwal, A., Esler, M., Socratous, F., & Kaye, D. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01121-4 · Cited by 81
Rozec, B. R., Erfanian, M., Laurent, K., Trochu, J., & Gauthier, C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.057 · Cited by 80
Goldsmith, R. L., Bigger, J. T., Bloomfield, D. M., Krum, H., Steinman, R. C., Sackner‐Bernstein, J., & Packer, M. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00616-4 · Cited by 80
Moura, E., Afonso, J., Hein, L., & Vieira‐Coelho, M. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706950 · Cited by 79
Lymperopoulos, A., Rengo, G., Zincarelli, C., Soltys, S., & Koch, W. J. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300371 · Cited by 79
Self-citationNeurohumoral Pathways in Heart Failure With Preserved Systolic Function
Hogg, K. J., & McMurray, J. J. V. (2005) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2005.02.001 · Cited by 76
The low-affinity site of the β1-adrenoceptor and its relevance to cardiovascular pharmacology
Kaumann, A. J., & Molenaar, P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.03.009 · Cited by 75
Rengo, G., Leosco, D., Zincarelli, C., Marchese, M., Corbi, G., Liccardo, D., Filippelli, A., Ferrara, N., Lisanti, M. P., Koch, W. J., et al. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00702.2009 · Cited by 75
Self-citationEffect of α1-adrenergic receptors in cardiac pathophysiology
Shannon, R. P., & Chaudhry, M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.05.017 · Cited by 74
Effect of Sympathoinhibition on Exercise Performance in Patients With Heart Failure
Lang, C. C., Rayos, G. H., Chomsky, D. B., Wood, A. J. J., & Wilson, J. R. (1997) · Circulation · doi:10.1161/01.cir.96.1.238 · Cited by 73
GRK2 Inhibition in Heart Failure: Something Old, Something New
Lymperopoulos, A., Rengo, G., & Koch, W. J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799040510 · Cited by 72
Self-citationRengo, G., Filardi, P. P., Femminella, G. D., Liccardo, D., Zincarelli, C., de Lucia, C., Pagano, G., Marsico, F., Lymperopoulos, A., & Leosco, D. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.966895 · Cited by 71
Self-citationOsadchii, O. E., Norton, G. R., McKECHNIE, R. E., Deftereos, D., & Woodiwiss, A. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00740.2006 · Cited by 71
Soppa, G. K. R., Lee, J., Stagg, M. A., Felkin, L. E., Barton, P. J. R., Siedlecka, U., Youssef, S., Yacoub, M. H., & Terracciano, C. M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvm106 · Cited by 70
Biolo, A., Clausell, N., dos Santos, K. G., Salvaro, R. G., Ashton‐Prolla, P., Borges, A. P., & Rohde, L. E. P. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.070 · Cited by 67
Leosco, D., Rengo, G., Iaccarino, G., Filippelli, A., Lymperopoulos, A., Zincarelli, C., Fortunato, F., Golino, L., Marchese, M., Esposito, G., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00308.2007 · Cited by 67
Self-citationDu, X., Gao, X. J., Kiriazis, H., MOORE, X., MING, Z., Su, Y. R., Finch, A. M., Hannan, R. D., Dart, A. M., & GRAHAM, R. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.06.015 · Cited by 66
Rengo, G., Lymperopoulos, A., Zincarelli, C., Femminella, G. D., Liccardo, D., Pagano, G., de Lucia, C., Cannavò, A., Gargiulo, P., Ferrara, N., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01972.x · Cited by 65
Self-citationClenbuterol Increases Lean Muscle Mass but Not Endurance in Patients With Chronic Heart Failure
Kamalakkannan, G., Petrilli, C. M., George, I., LaManca, J. J., McLaughlin, B. T., Shane, E. J., MANCINI, D. M., & Maybaum, S. W. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.01.013 · Cited by 64
Catecholamine-mediated constrictor effects of aldosterone on vascular smooth muscle
Weber, M. A., & Purdy, R. E. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90441-6 · Cited by 63
Aggarwal, A., Esler, M., Lambert, G. W., Hastings, J. A., Johnston, L., & Kaye, D. M. (2002) · Circulation · doi:10.1161/hc0902.105724 · Cited by 60
Increased Plasma Norepinephrine Levels During Prazosin Therapy for Severe Congestive Heart Failure
Colucci, W. S., Williams, G. H., & D, E. B. M. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-452 · Cited by 59
β-adrenergic signaling in heart failure—adapt or die
Thomas Eschenhagen, A. (2008) · Nature Medicine · doi:10.1038/nm0508-485 · Cited by 59
O’Connor, C. M., Fiuzat, M., Carson, P. E., Anand, I. S., Plehn, J. F., Gottlieb, S. S., Silver, M. A., Lindenfeld, J., Miller, A. B., White, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044324 · Cited by 58
Blockade of β1- and desensitization of β2-adrenoceptors reduce isoprenaline-induced cardiac fibrosis
Brouri, F., Hanoun, N., Médiani, O., Saurini, F., Hamon, M., Vanhoutte, P. M., & Lechat, P. P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.063 · Cited by 54
Cardiovascular reflexes mediated by sympathetic afferent fibers
Malliani, A., Pagani, M., Pizzinelli, P., Furlan, R., & Guzzetti, S. (1983) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(83)90082-6 · Cited by 53
Ventricular myocardial catecholamines in primates.
Pierpont, G. L., DeMaster, E. G., Reynolds, S., Pederson, J. E., & Cohn, J. N. (1985) · PubMed · Cited by 52
Khan, M. H., & Sinoway, L. I. (2000) · Heart Failure Reviews · doi:10.1023/a:1009802308872 · Cited by 50
Adams, V., Doring, C., & Gerhard, S. (2007) · Frontiers in bioscience · doi:10.2741/2680 · Cited by 48
The “Unsympathetic” Nervous System of Heart Failure
Floras, J. S. (2002) · Circulation · doi:10.1161/01.cir.0000013788.71817.16 · Cited by 48
Future G protein-coupled receptor targets for treatment of heart failure
Rengo, G., Lymperopoulos, A., & Koch, W. J. (2009) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-009-0033-5 · Cited by 44
Self-citationLeineweber, K., Wangemann, T., Giessler, C., Bruck, H., Dhein, S., Kostelka, M., Mohr, F., Silber, R.-E., & Brodde, O.-E. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02168-x · Cited by 43
Cresci, S., Dorn, G. W., Jones, P. G., Beitelshees, A. L., Li, A. Y., Lenzini, P. A., Province, M. A., Spertus, J. A., & Lanfear, D. E. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.051 · Cited by 40
Reducing the Risk of Sudden Death in Heart Failure With β-Blockers
Adamson, P. B., & Gilbert, E. M. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.08.213 · Cited by 36
Age-related changes in adrenergic neuroeffector transmission
Docherty, J. R. (2002) · Autonomic Neuroscience · doi:10.1016/s1566-0702(01)00375-7 · Cited by 35
Acute and Short-Term Effects of Clonidine in Heart Failure
Giles, T. D., Thomas, M. G., Quiroz, A. C., Rice, J. C., Plauche, W. E., & Sander, G. E. (1987) · Angiology · doi:10.1177/000331978703800707 · Cited by 34
Kubo, T., Parker, J. D., Azevedo, E. R., Atchison, D. J., Newton, G. E., Picton, P. E., & Floras, J. S. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.10.012 · Cited by 33
Regitz‐Zagrosek, V., Leuchs, B., Bossaller, C., Sehested, J., Rappolder, M., & Fleck, E. (1991) · European Heart Journal · doi:10.1093/eurheartj/12.suppl_d.171 · Cited by 32
Xu, X.-L., Zang, W., Lü, J., Kang, X., Li, M., & Yu, X. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.04.005 · Cited by 24
Sympathoinhibitory Response to Clonidine Is Blunted in Patients With Heart Failure
Lang, C. C., Stein, C. M., Nelson, R. A., He, H. B., Belas, F. J., Blair, I. A., Wood, M., & Wood, A. J. J. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.392 · Cited by 21
Chemello, D., Rohde, L. E. P., dos Santos, K. G., Silvello, D., Goldraich, L. A., Pimentel, M., Rosa, P. R., Zimerman, L. I., & Clausell, N. (2010) · EP Europace · doi:10.1093/europace/euq040 · Cited by 18
Lymperopoulos, A. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.197020 · Cited by 15
Self-citationTriposkiadis, F. K., Dalampiras, P., Kelepeshis, G. A., Skoularigis, J. S., & Sitafidis, G. (2008) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp46136 · Cited by 13
Research works printed but not linked: 3
- 10.1038/clpt.2010.315 · doi:10.1038/clpt.2010.315
- 10.1016/j.mce.2003.02.001 · doi:10.1016/j.mce.2003.02.001
- 10.2217/pgs.11.178 · doi:10.2217/pgs.11.178
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Role of the Autonomic Nervous System in Atrial Fibrillation: Pathophysiology and Therapy
Chen, P.-S., Chen, L. S., Fishbein, M. C., Lin, S.-F., & Nattel, S. (2014) · Circulation Research · doi:10.1161/circresaha.114.303772 · Cited by 790
Pathophysiology of Takotsubo Syndrome
Pelliccia, F., Kaski, J. C., Crea, F., & Camici, P. G. (2017) · Circulation · doi:10.1161/circulationaha.116.027121 · Cited by 732
Neurohormonal activation in heart failure with reduced ejection fraction
Hartupee, J., & Mann, D. L. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.163 · Cited by 709
The Autonomic Nervous System and Heart Failure
Florea, V. G., & Cohn, J. N. (2014) · Circulation Research · doi:10.1161/circresaha.114.302589 · Cited by 572
Metadata
- Authors
- Lymperopoulos, A., Rengo, G., & Koch, W. J.
- Venue
- Circulation Research
- Published
- 2013-08-30
- Volume
- 113
- Issue
- 6
- Pages
- 739-753
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2148598424
- Cited by
- 607
- References
- 163
- FWCI
- 26.27
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.